Member Info for Gunner68

Great news Rich3 and des both good luck going forward

Surfie I’m not a big fan of Parker’s as most on here will know including himself ,but I like to read SOG findings as I think they give an insight into what we might possibly have now there’s a big difference in what we could have , what the BOD say we could have but when they don’t engage with shareholders to allow us to find answers to questions no doubt everyone will have. that’s my biggest bug bear and I’m still of the opinion Parker is not the man for the job .Also please as many as possible get to the AGM this year and put your questions directly too them I know they don’t like being challenged but they need to remember it’s OUR company not theirs and so far the SP is not matching what they are trying to say we have if what we have is so good about time they showed their commitment and brought in

GLA

GLA

laz maybe some never due to the fact it’s gone from 4.50 to 3.50 to 2.50 to 1.50 to 50 to 10 now that doesn’t install confidence how many hnwi got in at 3.50 2.50 and got burnt and we were within a knats ******* of going under who was it who decided to act at the 10p point ? these questions will be asked at the agm so maybe some are just sick of it constantly going down and i wonder if parker has been looked after by his hnwi chums to allow such low entry points . the ph valuation again way off we need money in hopefully from 737 but imho expecting it to be handed back and then saying no thanks there is a point when people say enough and the bod haven’t helped with no engagement with the shareholders some may not have as deep pockets as yourself so i can see why people use their opinion .the bod have learnt nothing from the last agm and i believe they are cowards for not engaging all my own opinions let’s hope we can gain momentum going in the right direction for once

gla

Would be nice if one day they actually buy shares like we have too which would increase the SP instead of it constantly drifting down

Come on Parker start engaging with the shareholders and not just your hnwi chums and again I don’t think I’ll be voting for a pay rise this year if you ve got the neck to ask for it ,again sp down over 50pc from last dec I don’t think you ve got the hang of this share holder value malarkey

GLA

1802 back in play now we are talking

GLA

Afternoon PCS all good here as hopefully it is with you thanks let’s hope we see some movement in the right direction very frustrating and even more lack of communication from the BOD I think they have learnt nothing from the last AGM . And you know what my view was last time .I hope there is longer than an hour this year as I believe those not able to but have submitted Qs should have the respect of the BOD to be able to have it answered on the day of the AGM . I’m sure there is still many Q s that need answered . I also bet not a single person on here expected a second tox study and look forward to the reasoning why and again another delay

hopefully see you at the AGM again more advance notice of the date would be much appreciated

GLA

RNS dated 6th March

Sareum is evaluating potential further development opportunities for SRA737 with CPF and will provide further updates as appropriate.

So they will know who it is and how it’s going

GLA

Would be nice to see that start moving again

GLA

Some big names attending there today GSK Eli Lilly let’s see if this could have an effect on investment into the Pharma industry.

GLA

Dr Stephen Parker, Executive Chairman of Sareum, commented:

"We are delighted to secure this funding which, together with the tax credit from Australia, enables us to progress our lead programme, SDC-1801, towards Phase 2 readiness. The recent successful completion of our Phase 1 trial, demonstrating SDC-1801's favourable safety profile, combined with impressive pharmacokinetics and biomarker effects, has reinforced our confidence in its potential as a best-in-class TYK2/JAK1 inhibitor.

"With sustained high blood levels, positive side-effect profile and absence of changes to blood components, SDC-1801 demonstrates significant advantages in the competitive landscape of autoimmune disease treatments. The planned longer-term toxicology studies are critical next steps, not only for regulatory purposes but also to enhance SDC-1801's value proposition for potential out-licensing partners.

"We believe SDC-1801 has the potential to offer increased efficacy compared to existing therapies in a number of autoimmune conditions where there is a serious unmet medical need. This funding brings us closer to realising that potential and potentially delivering a new, more effective treatment option for millions of patients worldwide."

The last paragraph increased efficacy and new more effective treatment

Now would be a great time for an investor meet to explain instead of everyone guessing

GLA

Why raise if we are that good we shouldn’t need too and if we did we need new management as the current ones arnt cutting the mustard and what a surprise we failed the timeline again

Hope to be proven wrong

GLA

And tax credits

I think a few held on because of the Agile Angle but was only going to be fast tracked if a ph1a trial had been completed

GLA

Laz I appreciate your reply as always . What annoys me is the fact funding was available out there at the time according to someone at the AGM who actually stood up and said that ,the BOD were lazy or did not have contacts out there which I would expect someone to have contacts especially if the product you are trying to market is as good as you say and who advised them . Parker could of held the investor meet to get interest but did they No and why not they were happy to take investors money but not answer questions which I’m sure many will have totally spineless the reaction of Parker getting full time chair did not exactly set us alight and not surprised after his disastrous stint with the cannabis firm but same MO consolidate and see the sp nose dive

Going into trial comment Sp rose then nose dived as we all know application turned down

737 said things would be different when returned not even a seat at the table

During Covid Agile funding which we never had a hope in hells chance we are still waiting now for data and which a few probably invested due to the funding including the HNWI

And I’m sure there’s more

Happy with the science Yes how the company has been run NO

To me respect is earned and he has still to do that if anyone would like to defend then please do I’m happy to listen

GLA have a great weekend see what next week brings

Parker will probably get RF and PH employer of the year, again who initiated the shareholders to help the company out of trouble and why did they just sit back and watch the SP drop ? Question to be answered at the AGM .

GLA

I’d guess it’s easy for the mm s to keep lowering the sp let’s face it SAR either miss the expected date for news or are bang on the last day news expected just go back over the RNS dates unless they are going to surprise us on this one which I very much doubt

GLA

Looks like RF or PH trying to keep the SP low who else would sell when news could drop anytime

GLA

Are we due them this month as well ?

Don’t worry about it Parker and Co definately don’t give a sh@t look at last time when they allowed it to drift down happy to take the wages and do nothing carnt even be Ar@ed to engage with shareholders unless asking for money and Parker if your reading more than an hour for the AGM I’m sure there’s plenty of Qs shareholders have got for you this year

One being was it only pressure from shareholders that made the BOD act when we were close to going bankrupt yes I am a firm believer Parker is not the bloke to chair this firm and if nothing has improved by Xmas he is voted out

Https://www.linkedin.com/pulse/non-receptor-tyrosine-protein-kinase-tyk2-market-insights-mgjuf/

Apologies if already posted

GLA